The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.00
Bid: 325.50
Ask: 326.50
Change: -0.50 (-0.15%)
Spread: 1.00 (0.307%)
Open: 326.50
High: 326.50
Low: 323.00
Prev. Close: 326.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

9 Nov 2023 07:00

RNS Number : 8547S
Morgan Advanced Materials PLC
09 November 2023
 

 

 

Press Release

Morgan Advanced Materials plc

9 November 2023

 

Trading Update

Strong financial position, growth outlook unchanged

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for technically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2023.

Current Trading

Sales for the nine months to September 2023 were 2.4% higher for the Group, on an organic constant-currency basis, compared with the same period last year. Our recovery from the cyber incident we experienced at the start of the year has progressed as planned. By business unit, organic constant-currency sales performance for the nine months to September 2023, compared with the same period last year, were as follows:

 

Thermal Ceramics

+0.9%

Molten Metal Systems

-7.2%

Electrical Carbon

+6.5%

Seals and Bearings

-5.4%

Technical Ceramics

+7.7%

 

Outlook

Our outlook for full year organic revenue growth is unchanged at 2-4%. The group has continued to benefit from strong growth in its Semiconductor, Healthcare and Aerospace end-markets, offsetting weakness in European and China industrial markets. Seals & Bearings performance was influenced in part by phasing of armour orders.

Margins have continued to improve sequentially, despite an adverse movement in FX impacting the second half by circa £3m.

We continue to pursue opportunities to remove cost to ensure we enter 2024 with the right cost structure. Although uncertainty remains around some of our end markets, looking forward we expect continued margin improvement and good growth in H1 2024, especially given the cyber incident in the comparative period. In particular, we expect sustained growth in Semiconductor driven by demand for Silicon Carbide applications in power electronics.

 

Pete Raby, Chief Executive Officer, said:

"Our business is growing as anticipated, benefitting from our leading, differentiated positions in selected markets and despite the challenging environment, with inflation continuing to be more than offset by pricing.

Our Board remains committed to our financial framework. Investment in capacity for our faster growing segments is accelerating, and we continue to investigate inorganic investments as well as consider opportunities for enhanced returns to shareholders."

The full year results are expected to be released on 14 March 2024. A Capital Markets Event will be held during Q2 2024, with updates on progress in our faster growing markets, opportunities for efficiency improvement and investment plans.

 

For further enquiries:

Pete Raby

Morgan Advanced Materials plc

01753 837000

Richard Armitage

Nina Coad

Brunswick

0207 404 5959

 

1. Company-compiled summary of current analysts' forecasts for adjusted operating profit for 2023 is a range of £120.5 million to £125.0 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFPEEDDFFA
Date   Source Headline
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding
10th May 20134:55 pmRNSResult of AGM
10th May 201310:00 amRNSAppointment of a Non-Executive Director
10th May 20137:00 amRNSInterim Management Statement
24th Apr 201312:09 pmRNSScrip Dividend Price
19th Apr 201311:20 amRNSDirector/PDMR Shareholding
10th Apr 201310:14 amRNSDirector/PDMR Shareholding
27th Mar 20135:38 pmRNSChange of Name
26th Mar 20134:25 pmRNSAnnual Financial Report
26th Mar 201311:44 amRNSDirector/PDMR Shareholding
14th Mar 20139:54 amRNSDirector/PDMR Shareholding
12th Mar 20131:50 pmRNSDirector/PDMR Shareholding
26th Feb 20133:55 pmRNSHolding(s) in Company
19th Feb 20131:09 pmRNSHolding(s) in Company
19th Feb 20131:08 pmRNSHolding(s) in Company
14th Feb 20137:05 amRNSChange of responsibilities of a director
14th Feb 20137:00 amRNSFull Year Results
5th Feb 20135:40 pmRNSHolding(s) in Company
31st Jan 201310:44 amRNSTotal Voting Rights
18th Jan 201312:38 pmRNSHolding(s) in Company
15th Jan 20132:07 pmRNSDirector/PDMR Shareholding
10th Jan 20139:54 amRNSTotal Voting Rights
3rd Jan 20133:47 pmRNSIssue of Equity
18th Dec 20124:54 pmRNSBlocklisting Interim Review
11th Dec 20129:35 amRNSDirector/PDMR Shareholding
6th Dec 20129:59 amRNSDirector/PDMR Shareholding
6th Dec 20129:55 amRNSDirector/PDMR Shareholding
29th Nov 20129:07 amRNSScrip Dividend Price
30th Oct 20125:08 pmRNSHolding(s) in Company
30th Oct 20129:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.